Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Contivue Port Delivery Platform for nAMD Receives CE Mark

Summary by ophthalmologytimes.com
Roche's Contivue platform gains EU CE mark, offering innovative treatment for neovascular AMD with fewer injections and promising long-term vision outcomes.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

Drug Delivery BusinessDrug Delivery Business

Roche wins CE mark for Contivue drug-eluting eye implant

Roche announced today that it received CE mark approval for its port delivery platform containing its Susvimo therapeutic. The device, known as Contivue in Europe, comprises the eye implant through which Susvimo is delivered, plus four ancillary devices to initially fill, insert, refill and remove the implant if required. Susvimo (ranibizumab injection) 100 mg/mL remains under review in Europe for the treatment of neovascular age-related macular…

Read Full Article
ophthalmologytimes.comophthalmologytimes.com
Reposted by
modernretina.commodernretina.com

Contivue port delivery platform for nAMD receives CE mark

Roche's Contivue platform gains EU CE mark, offering innovative treatment for neovascular AMD with fewer injections and promising long-term vision outcomes.

Read Full Article
diarioestrategia.cldiarioestrategia.cl

Roche Receives the Ce Marking for 'Contivue', Its Ocular Management Platform with 'Susvimo' for Dmaen

Roche has announced that it has received the CE mark from the EU for its platform of ocular administration with 'Susvimo', that in Europe it will be called 'Contivue' and that it treats macular degeneration associated with the neovascular age (DMAEn).

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

diarioestrategia.cl broke the news in on Thursday, September 4, 2025.
Sources are mostly out of (0)

Similar News Topics

AMD icon

AMD

European Union icon

European Union

News
For You
SearchBlindspotLocal